Crown Bioscience has announced the launch of a novel bioinformatics tool, CrownSyn. Its goal is to make it easier for researchers to understand drug combination effects, and is now available as an add-on feature to all two-drug combinatorial studies conducted by Crown Bioscience.   Combination therapies can improve efficacy, overcome drug resistance and decrease toxicity. Crown Bioscience’s team of bioinformaticians developed CrownSyn to help clients evaluate the efficacy of two-drug com...